The results of these initial analyses provided primary evidence that overexpression of ACE2 receptor and enhanced CXCL10 cytokine expression might be the major possible reason for increased susceptibility and fatality of lung cancer patients towards COVID-19. The gene discussed is CXCL10; the disease is lung cancer.